V2ACT Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

V2ACT Therapeutics General Information

Description

Operator of oncology drug discovery company intended to serve the healthcare sector. The company develops and commercializes a product candidate, V2ACT Immunotherapy, that combines an oncolytic virus and neoantigen-primed adoptive cell therapy (NACT) for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 310
  • San Diego, CA 92109
  • United States
Primary Industry
Drug Discovery
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 310
  • San Diego, CA 92109
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

V2ACT Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore V2ACT Therapeutics‘s full profile, request access.

Request a free trial

V2ACT Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore V2ACT Therapeutics‘s full profile, request access.

Request a free trial

V2ACT Therapeutics FAQs

  • When was V2ACT Therapeutics founded?

    V2ACT Therapeutics was founded in 2019.

  • Where is V2ACT Therapeutics headquartered?

    V2ACT Therapeutics is headquartered in San Diego, CA.

  • What industry is V2ACT Therapeutics in?

    V2ACT Therapeutics’s primary industry is Drug Discovery.

  • Is V2ACT Therapeutics a private or public company?

    V2ACT Therapeutics is a Private company.

  • What is V2ACT Therapeutics’s current revenue?

    The current revenue for V2ACT Therapeutics is .

  • Who are V2ACT Therapeutics’s investors?

    Genelux and TVAX Biomedical have invested in V2ACT Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process